These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 30513224)

  • 1. Therapeutic potential of Panax ginseng and its constituents, ginsenosides and gintonin, in neurological and neurodegenerative disorders: a patent review.
    Rajabian A; Rameshrad M; Hosseinzadeh H
    Expert Opin Ther Pat; 2019 Jan; 29(1):55-72. PubMed ID: 30513224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective Effects of Ginseng Phytochemicals: Recent Perspectives.
    Huang X; Li N; Pu Y; Zhang T; Wang B
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31416121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study on anticoagulant activities of three Chinese herbal medicines from the genus Panax and anticoagulant activities of ginsenosides Rg1 and Rg2.
    Li CT; Wang HB; Xu BJ
    Pharm Biol; 2013 Aug; 51(8):1077-80. PubMed ID: 23742679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ginseng on Nuclear Hormone Receptors.
    Park J; Bui PTC; Song H; Kim SK; Rhee DK; Kim EY; Rhyu MR; Lee MS; Lee YJ
    Am J Chin Med; 2017; 45(6):1147-1156. PubMed ID: 28830207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of ginseng in medicine with emphasis on neurodegenerative disorders.
    Radad K; Gille G; Liu L; Rausch WD
    J Pharmacol Sci; 2006 Mar; 100(3):175-86. PubMed ID: 16518078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Panax ginseng components and the pathogenesis of Alzheimer's disease (Review).
    Razgonova MP; Veselov VV; Zakharenko AM; Golokhvast KS; Nosyrev AE; Cravotto G; Tsatsakis A; Spandidos DA
    Mol Med Rep; 2019 Apr; 19(4):2975-2998. PubMed ID: 30816465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yin and Yang of ginseng pharmacology: ginsenosides vs gintonin.
    Im DS; Nah SY
    Acta Pharmacol Sin; 2013 Nov; 34(11):1367-73. PubMed ID: 24122014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Component analysis and target cell-based neuroactivity screening of Panax ginseng by ultra-performance liquid chromatography coupled with quadrupole-time-of-flight mass spectrometry.
    Yuan J; Chen Y; Liang J; Wang CZ; Liu X; Yan Z; Tang Y; Li J; Yuan CS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Dec; 1038():1-11. PubMed ID: 27776327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Panax ginseng and aging related disorders: A systematic review.
    de Oliveira Zanuso B; de Oliveira Dos Santos AR; Miola VFB; Guissoni Campos LM; Spilla CSG; Barbalho SM
    Exp Gerontol; 2022 May; 161():111731. PubMed ID: 35143871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Red American ginseng: ginsenoside constituents and antiproliferative activities of heat-processed Panax quinquefolius roots.
    Wang CZ; Aung HH; Ni M; Wu JA; Tong R; Wicks S; He TC; Yuan CS
    Planta Med; 2007 Jun; 73(7):669-74. PubMed ID: 17538869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ginsenosides: A Potential Neuroprotective Agent.
    Zheng M; Xin Y; Li Y; Xu F; Xi X; Guo H; Cui X; Cao H; Zhang X; Han C
    Biomed Res Int; 2018; 2018():8174345. PubMed ID: 29854792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-ginsenoside nicotinic activity in ginseng species.
    Lewis R; Wake G; Court G; Court JA; Pickering AT; Kim YC; Perry EK
    Phytother Res; 1999 Feb; 13(1):59-64. PubMed ID: 10189953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Panax ginseng clinical trials: Current status and future perspectives.
    Fan S; Zhang Z; Su H; Xu P; Qi H; Zhao D; Li X
    Biomed Pharmacother; 2020 Dec; 132():110832. PubMed ID: 33059260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects and mechanisms of ginseng and ginsenosides on cognition.
    Smith I; Williamson EM; Putnam S; Farrimond J; Whalley BJ
    Nutr Rev; 2014 May; 72(5):319-33. PubMed ID: 24666107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reductions in levels of the Alzheimer's amyloid beta peptide after oral administration of ginsenosides.
    Chen F; Eckman EA; Eckman CB
    FASEB J; 2006 Jun; 20(8):1269-71. PubMed ID: 16636099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gintonin: a novel ginseng-derived ligand that targets G protein- coupled lysophosphatidic acid receptors.
    Nah SY
    Curr Drug Targets; 2012 Dec; 13(13):1659-64. PubMed ID: 23017203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ginsenosides in central nervous system diseases: Pharmacological actions, mechanisms, and therapeutics.
    Lu J; Wang X; Wu A; Cao Y; Dai X; Liang Y; Li X
    Phytother Res; 2022 Apr; 36(4):1523-1544. PubMed ID: 35084783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ongoing Research on the Role of Gintonin in the Management of Neurodegenerative Disorders.
    Ikram M; Ullah R; Khan A; Kim MO
    Cells; 2020 Jun; 9(6):. PubMed ID: 32549286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulfur fumigation reducing systemic exposure of ginsenosides and weakening immunomodulatory activity of ginseng.
    Ma B; Kan WL; Zhu H; Li SL; Lin G
    J Ethnopharmacol; 2017 Jan; 195():222-230. PubMed ID: 27856301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible differential induction of phase 2 enzyme and antioxidant pathways by american ginseng, Panax quinquefolius.
    Lee LS; Wise SD; Chan C; Parsons TL; Flexner C; Lietman PS
    J Clin Pharmacol; 2008 May; 48(5):599-609. PubMed ID: 18319359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.